Clinical Trial Update: Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Tauroursodeoxycholic acid to Ursofalk for adult primary biliary cholangitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Tauroursodeoxycholic acid (tauroursodeoxycholic acid)
• Ursofalk (Ursodeoxycholic acid)

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: COMPLETED